SYNLAB AG Deutsche Boerse AG

SYAB

DE000A2TSL71

Healthcare Facilities & Services

Real-time Estimate Tradegate Other stock markets 03:02:58 2024-04-23 pm EDT			5-day change	1st Jan Change
10.49 ^EUR	+0.10%		-2.60%	-8.15%

Apr. 22	Synlab Faces Cyber Attack in Italy	MT
Apr. 21	Dpa-AFX Overview: COMPANIES - The most important news from the weekend	DP

SYNLAB : Goldman Sachs maintains a Buy rating

November 25, 2021 at 01:22 pm EST

Goldman Sachs analyst Veronika Dubajova maintains his Buy rating on the stock. The target price is set at 23.80 versus 23.30 EUR.

Latest news about SYNLAB AG

Synlab Faces Cyber Attack in Italy	Apr. 22	MT
Dpa-AFX Overview: COMPANIES - The most important news from the weekend	Apr. 21	DP
SYNLAB AG(XTRA:SYAB) dropped from S&P Global BMI Index	Apr. 14	CI
Tranche Update on SYNLAB AG's Equity Buyback Plan announced on September 22, 2022.	Apr. 05	CI
Dpa-AFX Overview: COMPANIES from 25.03.2024 - 15:15	Mar. 25	DP
Transcript : SYNLAB AG, 2023 Earnings Call, Mar 25, 2024	Mar. 25
Laboratory chain Synlab earns significantly less in 2023 - cancels dividend	Mar. 25	DP
SYNLAB AG Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 24	CI
Fitch Keeps Synlab on Rating Watch Negative Amid Cinven Takeover	Mar. 22	MT
SYNLAB : JP Morgan sticks Neutral	Dec. 05	ZD
Moody's Withdraws Synlab Rating	Dec. 05	MT
Financial investor Singer also gets involved in Synlab takeover	Nov. 23	DP
Dpa-AFX Overview: COMPANIES from 08.11.2023 - 15:15	Nov. 08	DP
Transcript : SYNLAB AG, Q3 2023 Earnings Call, Nov 08, 2023	Nov. 08
SYNLAB : Jefferies reiterates its Neutral rating	Nov. 08	ZD
Rising costs cause earnings at laboratory service provider Synlab to shrink	Nov. 08	DP
SYNLAB AG Provides Earnings Guidance for the Year 2023	Nov. 08	CI
SYNLAB AG Reports Earnings Results for the Nine Months Ended September 30, 2023	Nov. 07	CI
FTSE 100 Closes Friday Lower, Weighed Down by Falling Oil Prices	Nov. 03	DJ
Desert Frankfurt: Of canceled borse walks and farewells	23-10-12	DP
Fitch Places Synlab on Rating Watch Negative Following Cinven Offer	23-10-10	MT
Synlab Launches Revolutionary Bipolar Disorder Diagnostic Test	23-10-10	CI
FTSE 100 Closes Up, Capping off a Positive Quarter	23-09-29	DJ
Dpa-AFX Overview: COMPANIES of 09/29/2023 - 3:15 PM	23-09-29	DP
SYNLAB : Jefferies remains Neutral	23-09-29	ZD

Synlab AG is a Germany based clinical laboratory and medical diagnostic services provider. The Company is engaged in laboratory services for human and veterinary medicine, as well as environmental analysis.

Sector

Healthcare Facilities & Services

Calendar

2024-05-07 - Q1 2024 Earnings Call

More about the company

Income Statement Evolution

More financial data

Ratings for SYNLAB AG

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

10.56 EUR

Average target price

14.5 EUR

Spread / Average Target

+37.31%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
SONIC HEALTHCARE LIMITED	-16.30%	8.18B
RADNET, INC.	+41.03%	3.51B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-29.20%	2.9B
DR. LAL PATHLABS LIMITED	-12.74%	2.25B
FLEURY S.A.	-18.35%	1.47B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-39.52%	1.22B
METROPOLIS HEALTHCARE LIMITED	+9.05%	1.1B
ADICON HOLDINGS LIMITED	-13.80%	1.09B
H.U. GROUP HOLDINGS, INC.	-10.01%	877M

Medical & Diagnostic Laboratories

SYNLAB AG Deutsche Boerse AG

Equities

SYAB

DE000A2TSL71

Healthcare Facilities & Services

SYNLAB : Goldman Sachs maintains a Buy rating

Latest news about SYNLAB AG

Chart SYNLAB AG

Company Profile

Income Statement Evolution

Ratings for SYNLAB AG

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Medical & Diagnostic Laboratories